Skip to content

Multidomain Intervention Based on ICOPE

FORMULA 100: an ICOPE-based Multidomain Intervention to Promote Active and Healthy Ageing.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07829120
Acronym
FORMULA 100
Enrollment
250
Registered
2026-09-18
Start date
2025-12-01
Completion date
2027-03-31
Last updated
2026-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrinsic Capacity

Keywords

intrinsic capacity, multidomain intervention, older adults

Brief summary

FORMULA 100 is a prospective, single-arm feasibility study conducted at two Active Ageing Centers in Monza, Italy, involving community-dwelling adults aged 65 years and older. The study will test whether an Integrated Care for Older People (ICOPE)-based care pathway can be implemented in this setting. Participants will first be screened for possible decline in intrinsic capacity (IC). Those enrolled will then undergo a multidimensional assessment and receive a personalized 3-month intervention tailored to their needs. The intervention may address physical, cognitive, nutritional, psychological, sensory, and social needs and may also include a review of medications. Participants will be reassessed after 3 months and again after 6 months. The main study outcome is the proportion of participants who complete the 6-month follow-up. About 300 people are expected to be screened, with a target enrollment of 250 participants.

Interventions

Following the in-depth assessment, each participant receives a personalized 3-month multidomain intervention plan tailored to identified IC impairments, clinical status, preferences, and social context. A multidisciplinary team provides multicomponent physical exercise based on Vivifrail for all participants, alongside targeted interventions for cognitive impairment, overt malnutrition or risk of malnutrition, depressive symptoms, sensory deficits, and social isolation. Regular medications are also reviewed using STOPP/START criteria, with recommendations communicated to the participant and primary care physician.

Sponsors

University of Milano Bicocca
Lead SponsorOTHER
Cariplo Foundation
CollaboratorUNKNOWN

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Prospective, single-arm feasibility study of a multidomain intervention conducted at two Active Ageing Centers (AACs) in Monza, Lombardy (Italy).

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 65 years * Attendance at one of the Active Ageing Centers participating in the project * Evidence of impairment in at least one key domain of intrinsic capacity, as identified through the first-level ICOPE screening * Ability to walk independently (with or without a walking aid) * Ability to communicate and cooperate with the research team

Exclusion criteria

* Clinical conditions precluding completion of the first-level ICOPE screening or safe participation in the study, including severe dementia, bilateral blindness, end-stage diseases (e.g., Child-Pugh class C liver cirrhosis, stage 5 chronic kidney disease, chronic obstructive pulmonary disease Global Initiative for Chronic Obstructive Lung Disease group D, end-stage heart failure, or advanced cancer) * Concurrent participation in another clinical study * Refusal or inability to provide written informed consent

Design outcomes

Primary

MeasureTime frameDescription
ICOPE-based program feasibility, operationalized as the study completion rate at 6 months.6 monthsThis retention rate is defined as the proportion of enrolled participants who complete the entire study pathway, with a prespecified feasibility target of ≥80%.

Secondary

MeasureTime frameDescription
Prevalence of IC-domain impairmentsBaselineBaseline prevalence of impairment in each IC domain, as identified through the first-level screening and further confirmed through the in-depth assessment
Prevalence of frailtyBaselineBaseline prevalence of frailty
Adherence to multidomain interventions3 monthsMean proportion of prescribed intervention sessions completed
Participant satisfaction3 months and 6 monthsLikert-5 point questionnaire

Countries

Italy

Contacts

CONTACTMaria Cristina Ferrara, Medical doctor and PhD
mariacristina.ferrara@unimib.it+39 0392339719
PRINCIPAL_INVESTIGATORGiuseppe Bellelli, Medical doctor, full professor

University of Milano-Bicocca, IRCCS Foundation San Gerardo dei Tintori

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 19, 2026